David M. Iovannisci

Los Angeles County Department of Public Health, USA


David M. Iovannisci earned a M.S. degree in microbiology and a Ph.D. degree in biochemistry from the University of Kentucky, Lexington, KY, USA. Following postdoctoral studies at Texas A&M University and Harvard Medical School, he was employed at Applied Biosystems where he codeveloped the oligonucleotide ligation assay which serves as the basis of numerous genotyping methodologies including the Illumina bead array and multiplex ligation probe amplification (MLPA). Also at Applied Biosystems, Iovannisci was a member of the team that developed the capillary electrophoresis sequencer, which revolutionized genome analysis and resulted in the sequencing of the human genome. Iovannisci also coestablished and managed a basic research laboratory at Children’s Hospital Oakland Research Institute, where he studied the role of gene-environment interactions as risk factors for birth defects and genetic risk factors for the development of atherosclerosis. A life-long student of microbiology, he also generated morphological, physiological, and molecular evidence for the presence of a sexual stage in leishmanial blood parasites and developed a novel chimeric gene fusion between a single chain variable antibody fragment and a human apolipoprotein, for use as a targeted drug delivery system in the treatment of protozoan and fungal infections. Iovannisci has served on the editorial board and/or as a peer reviewer for more than a dozen scientific journals and as a beta test site in the development of numerous scientific products including genotyping platforms, modified DNA polymerases and other enzymes, and genetic analysis/data management software tools. Iovannisci is currently a Molecular Epidemiologist with the Los Angeles County Public Health Department.

Biography Updated on 15 June 2017

Scholarly Contributions [Data Provided by ]